Thymalin
Thymalin is a polypeptide complex extracted from calf thymus, developed by the Khavinson research group in Russia, that has been studied mainly in Russian-language, non-blinded animal and small clinical studies for immune modulation and as a proposed "geroprotector," with limited independent replication outside that research tradition.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
What it does & how it works
Thymalin is a mixture of thymic polypeptides rather than a single defined peptide; two of its characterized active components are the dipeptides Lys-Glu (KE) and Glu-Trp (EW). In vitro work suggests KE stimulates macrophages, lymphocytes, and neutrophils, while EW is proposed to inhibit ACE2-related vasoconstrictive signaling; molecular modeling and cell-culture experiments suggest these short peptides can bind double-stranded DNA promoter regions and modulate transcription of genes tied to cytokine production (IL-1β, IL-6, TNF-α), though this proposed DNA-binding mechanism remains a hypothesis from a limited set of studies rather than an established pharmacological pathway.
Typical results seen in research
Most Thymalin evidence is animal or in vitro: rat studies show that local Thymalin injection around a bone defect increases T- and B-lymphocyte and macrophage activity and accelerates reparative bone regeneration, and human peripheral blood mononuclear cell cultures show reduced pro-inflammatory cytokine release. A non-randomized Russian clinical comparison in severe COVID-19 patients reported lower hospital mortality and improved blood counts with Thymalin versus standard therapy or tocilizumab. A long-term (6-8 year), non-blinded cohort study by the compound's originators in 266 elderly subjects reported large reductions in mortality and age-related disease incidence when Thymalin was combined with the pineal peptide Epithalamin; this is an extraordinary effect size reported by the product's own developers, published in a lower-impact journal, without independent replication, and should be treated with substantial caution.
How it’s commonly used
In the Russian/Eastern European research and clinical tradition, Thymalin has historically been administered via intramuscular injection courses; in preclinical studies it has also been administered by local injection into tissue surrounding an experimental defect.
- Neuro Endocrinology Letters · 2003 Peptides of pineal gland and thymus prolong human life
- International Journal of Molecular Sciences · 2023 The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
- Advances in Gerontology (Uspekhi Gerontologii) · 2022 Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.